DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PEXMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes
MAP kinase p38 alpha inhibitor
PEXMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
3750D0U8B5
Molecule Type:
Small molecule
Molecular Formula:
C31H33FN6O3
Molecular Weight:
556.64
AlogP:
6.07
PSA:
106.23
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CENICRIVIROC MESYLATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CENICRIVIROC MESYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R96TV84T21
Molecule Type:
Small molecule
Molecular Formula:
C42H56N4O7S2
Molecular Weight:
793.06
AlogP:
8.74
PSA:
85.69
HBD:
1.0
HBA:
#RotB:
17.0
Source:
RO4987655
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RO4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PL-225B
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Insulin-like growth factor I receptor inhibitor
PL-225B
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAVOXERTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
MAP kinase ERK1 inhibitor
RAVOXERTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
R6AXV96CRH
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClFN6O2
Molecular Weight:
440.87
AlogP:
3.16
PSA:
97.86
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UK-396,082
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UK-396,082
×
Maximum Phase:
1
First Approval:
None
UNII:
2Q5861SUIG
Molecule Type:
Small molecule
Molecular Formula:
C12H21N3O2
Molecular Weight:
239.32
AlogP:
1.28
PSA:
81.14
HBD:
2.0
HBA:
#RotB:
8.0
Source:
NANATINOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NANATINOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
YTL7A418KQ
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN6O2
Molecular Weight:
394.41
AlogP:
1.51
PSA:
103.27
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DUBERMATINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute
Unknown
DUBERMATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
14D65TV20J
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN7O2S
Molecular Weight:
516.07
AlogP:
3.61
PSA:
93.7
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AVE-9940
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
AVE-9940
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CX-157
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
CX-157
×
Maximum Phase:
1
First Approval:
None
UNII:
O6L62LZJ0Q
Molecule Type:
Small molecule
Molecular Formula:
C14H8F4O4S
Molecular Weight:
348.27
AlogP:
3.71
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
PHENFORMIN
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Diabetes Mellitus
Unknown
PHENFORMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
DD5K7529CE
Molecule Type:
Small molecule
Molecular Formula:
C10H15N5
Molecular Weight:
205.26
AlogP:
0.24
PSA:
97.78
HBD:
5.0
HBA:
#RotB:
3.0
Source:
HEMAY-022
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Receptor protein-tyrosine kinase erbB-2 inhibitor
HEMAY-022
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THELIATINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
THELIATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6ZZ3B7NZ0B
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06840003
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Oligodendroglioma
Unknown
PF-06840003
×
Maximum Phase:
1
First Approval:
None
UNII:
5K1FUI0T2C
Molecule Type:
Small molecule
Molecular Formula:
C12H9FN2O2
Molecular Weight:
232.21
AlogP:
1.44
PSA:
61.96
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DSP-2230
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
DSP-2230
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIRLOTAPIDE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
DIRLOTAPIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
578H0RMP25
Molecule Type:
Small molecule
Molecular Formula:
C40H33F3N4O3
Molecular Weight:
674.72
AlogP:
8.25
PSA:
83.44
HBD:
2.0
HBA:
#RotB:
9.0
Source:
PHENSERINE, (+)-
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
PHENSERINE, (+)-
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0O4TJ588O
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O2
Molecular Weight:
337.42
AlogP:
3.67
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BPN-14967
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14967
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-1064
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MK-1064
×
Maximum Phase:
1
First Approval:
None
UNII:
O812716S9E
Molecule Type:
Small molecule
Molecular Formula:
C24H20ClN5O3
Molecular Weight:
461.91
AlogP:
4.2
PSA:
99.12
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AV-412
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AV-412
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-960
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
TAK-960
×
Maximum Phase:
1
First Approval:
None
UNII:
3831VFM1ZB
Molecule Type:
Small molecule
Molecular Formula:
C27H34F3N7O3
Molecular Weight:
561.61
AlogP:
3.55
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SNS-062
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNS-062
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORM-13070 C-11
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ORM-13070 C-11
×
Maximum Phase:
1
First Approval:
None
UNII:
Y61S1UFN4Y
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3O3
Molecular Weight:
354.44
AlogP:
2.19
PSA:
47.06
HBD:
0.0
HBA:
#RotB:
5.0
Source:
1
2
…
61
62
63
64
65
66
67
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA